Raj K. Puri, MD, PhD

FDA/CBER
Director, Division of Cellular & Gene Therapies
Raj K. Puri, MD, PhD, oversees the evaluation, regulation and approval of cell and gene therapy and tissue engineered medical products. Dr. Puri also performs FDA's mission-relevant medical research to advance medical product development; in particular finding new cures for cancer and inflammatory diseases.